Dec 11, 2024 8:05am EST NeoGenomics’ Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma
Dec 09, 2024 8:10am EST NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting
Nov 19, 2024 8:15am EST NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment
Nov 08, 2024 7:00am EST NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference
